Registry of Patients With Hypophosphatasia

Part of paid clinical trials in Centennial, Colorado.

Sponsor
Alexion Pharmaceuticals, Inc.
Study ID
NCT02306720
Status
Enrolling By Invitation

Conditions

  • Hypophosphatasia (HPP)

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

In this prospective, observational, long term registry patients of all ages with a diagnosis of hypophosphatasia (HPP) are followed at participating sites in multiple countries.

Key Dates

Start date
Jan 20, 2015
Status verified
Feb 2026
Primary completion
Dec 31, 2031
Completion
Dec 31, 2031

Study Design

Enrollment
1,571 participants (estimated)

Primary Outcome Measure

Natural History Information [ Time Frame: 1 Year ]

Locations (20)

FacilityCityStateZIPSite coordinators
Research SiteCentennialColorado80112-
Research SiteHartfordConnecticut06106-
Research SiteTampaFlorida33606-
Research SiteDecaturGeorgia30033-
Research SiteBaltimoreMaryland21287-
Research SiteBostonMassachusetts02111-
Research SiteBostonMassachusetts02115-
Research SiteMinneapolisMinnesota55454-
Research SiteKansas CityMissouri64108-
Research SiteSt LouisMissouri63110-
Research SiteHackensackNew Jersey07601-
Research SiteMineolaNew York11501-
Research SiteDurhamNorth Carolina27710-
Research SiteCincinnatiOhio45229-
Research SiteColumbusOhio43205-
Research SitePittsburghPennsylvania15224-
Research SiteNashvilleTennessee37212-
Research SiteSalt Lake CityUtah84112-
Research SiteCharlottesvilleVirginia22903-
Research SiteMadisonWisconsin53792-

Find similar trials in Centennial, CO

By research site
Research Site· Centennial, COResearch Site· Hartford, CTResearch Site· Tampa, FLResearch Site· Decatur, GAResearch Site· Baltimore, MDResearch Site· Boston, MA